Characterization of hereditary inclusion body myopathy myoblasts: possible primary impairment of apoptotic events.
about
Insights into muscle degeneration from heritable inclusion body myopathiesGNE is involved in the early development of skeletal and cardiac muscleHereditary inclusion body myopathy: a decade of progressThe proteomic profile of hereditary inclusion body myopathyPreclinical assessment of wt GNE gene plasmid for management of hereditary inclusion body myopathy 2 (HIBM2)UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE) binds to alpha-actinin 1: novel pathways in skeletal muscle?Hereditary inclusion-body myopathy with sparing of the quadriceps: the many tiles of an incomplete puzzleGanglioside GM3 levels are altered in a mouse model of HIBM: GM3 as a cellular marker of the disease.Aberrant cell cycle reentry in human and experimental inclusion body myositis and polymyositisUDP-GlcNAc 2-Epimerase/ManNAc Kinase (GNE): A Master Regulator of Sialic Acid Synthesis.Perspectives on distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy: contributions from an animal model. Lack of sialic acid, a central determinant in sugar chains, causes myopathy?A preclinical trial of sialic acid metabolites on distal myopathy with rimmed vacuoles/hereditary inclusion body myopathy, a sugar-deficient myopathy: a review.Unfolded protein response and activated degradative pathways regulation in GNE myopathy.The hereditary inclusion body myopathy enigma and its future therapy.Safety and in vivo expression of a GNE-transgene: a novel treatment approach for hereditary inclusion body myopathy-2.Beyond glycosylation: sialic acid precursors act as signaling molecules and are involved in cellular control of differentiation of PC12 cells.Regulation and pathophysiological implications of UDP-GlcNAc 2-epimerase/ManNAc kinase (GNE) as the key enzyme of sialic acid biosynthesis.Foxo/atrogin induction in human and experimental myositis.Correction of the Middle Eastern M712T mutation causing GNE myopathy by trans-splicing.Hereditary Inclusion Body Myopathy (HIBM2)Increased amyloid β-peptide uptake in skeletal muscle is induced by hyposialylation and may account for apoptosis in GNE myopathy.Gne depletion during zebrafish development impairs skeletal muscle structure and function.Survival-apoptosis associated signaling in GNE myopathy-cultured myoblasts.Hyposialylation of neprilysin possibly affects its expression and enzymatic activity in hereditary inclusion-body myopathy muscle.GNE Myopathy and Cell Apoptosis: A Comparative Mutation Analysis.Role of IGF-1R in ameliorating apoptosis of GNE deficient cells.GNE myopathy: from clinics and genetics to pathology and research strategies.Function and Mutations of the GNE Gene Leading to Distal Myopathy with Rimmed Vacuoles/Hereditary Inclusion-Body Myopathy, Animal Models, and Potential TreatmentMuscle weakness correlates with muscle atrophy and precedes the development of inclusion body or rimmed vacuoles in the mouse model of DMRV/hIBMFighting the Cause of Alzheimer's and GNE Myopathy
P2860
Q26851967-1C00C962-8E86-4BFB-8502-BD9BB7000909Q27334498-B7E4AC06-DEBC-41AB-AC3E-80719F5D4E52Q28251720-15754EB2-FE97-4DF2-BB13-02D7C74AF652Q28477028-46DA2FDF-6210-4B4F-9C17-3EB6D8891485Q30489819-9BB99B69-DCF7-405F-AF07-D21F6A994095Q33344453-98991AFC-C822-44C4-8547-5B4E32AF5025Q33352578-EE6770B3-297A-48A3-A1BC-A825A66E3340Q33552330-F6FE5E42-E4C3-4825-9376-5075826A868DQ33784450-0EC4CF86-0E00-4C1A-80F8-3D1EC6F35B93Q34167791-D9AE8E39-0424-49B4-B1AA-F85551EEE966Q34171610-79BC98DE-4755-4424-B678-5556ACD3125CQ34409454-7E5F8B30-E5F5-4D0B-A577-9E8535C8A491Q36659841-F204A4E5-8B3D-40EE-8277-B5C4E73C23AAQ37329567-366BEEEE-DCB7-462F-A09F-EEE1A7F5CAD8Q37378486-FDD641F1-88BD-4E35-9547-65C102CCAC95Q37441229-D0F49752-DE27-4081-9541-8CC524F089B2Q37474841-90400E90-508E-4ECB-A701-35A5E6AB47FFQ37701112-E6A8915A-77B2-4B06-AD8D-A6DD31E4B55AQ39058755-E6BB850D-D716-4DDE-99B3-175FE28C57CEQ39911980-64567A90-FCD6-40EF-B104-C7D516D89815Q41869194-F0C39B96-B956-40C7-A71F-789FB7C01517Q45862019-6B33B7EF-91E4-4A73-B4AD-9DB4B760E257Q45871239-C6FC0E02-D98B-48AC-82A5-3F11F8123714Q46817726-C98427C8-7DAC-42A0-BF70-771386DC0A91Q52943297-76BE0FB2-2DE2-437D-8D51-C6620BD53421Q54979444-E24A1A45-228D-4D0A-9BD5-90CDA3FFC3DDQ55268638-E71A7E1D-A937-4277-AE76-7A7FE7301CF1Q58036228-04B6FEC7-4443-4D45-8E33-A7FAD65684F9Q58036292-5804D18F-5A97-4B9B-94BB-5D8DA79EFBCEQ58122164-5CF42F24-5744-444A-8AD9-EB0A417CE52A
P2860
Characterization of hereditary inclusion body myopathy myoblasts: possible primary impairment of apoptotic events.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Characterization of hereditary ...... mpairment of apoptotic events.
@en
Characterization of hereditary ...... mpairment of apoptotic events.
@nl
type
label
Characterization of hereditary ...... mpairment of apoptotic events.
@en
Characterization of hereditary ...... mpairment of apoptotic events.
@nl
prefLabel
Characterization of hereditary ...... mpairment of apoptotic events.
@en
Characterization of hereditary ...... mpairment of apoptotic events.
@nl
P2093
P2860
P356
P1476
Characterization of hereditary ...... mpairment of apoptotic events.
@en
P2093
Ben-Bassat H
Levitzki R
Mitrani-Rosenbaum S
P2860
P2888
P304
P356
10.1038/SJ.CDD.4402208
P577
2007-08-03T00:00:00Z
P5875
P6179
1015011272